3.51
0.10 (2.93%)
| Penutupan Terdahulu | 3.41 |
| Buka | 3.44 |
| Jumlah Dagangan | 373,138 |
| Purata Dagangan (3B) | 931,878 |
| Modal Pasaran | 262,548,336 |
| Harga / Jualan (P/S) | 1.40 |
| Harga / Buku (P/B) | 0.640 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2025 - 12 May 2025 |
| Margin Keuntungan | -10.49% |
| Margin Operasi (TTM) | -29.95% |
| EPS Cair (TTM) | -0.260 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -50.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.56% |
| Nisbah Semasa (MRQ) | 9.95 |
| Aliran Tunai Operasi (OCF TTM) | 27.37 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 30.61 M |
| Pulangan Atas Aset (ROA TTM) | -2.68% |
| Pulangan Atas Ekuiti (ROE TTM) | -4.64% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | OraSure Technologies, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.83 |
|
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 4.07% |
| % Dimiliki oleh Institusi | 91.51% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 24 Mar 2025 | Pengumuman | OraSure Announces $40 Million Stock Repurchase Program |
| 25 Feb 2025 | Pengumuman | OraSure Reports Fourth Quarter 2024 Financial Results |
| 14 Feb 2025 | Pengumuman | OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th |
| 07 Jan 2025 | Pengumuman | CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents |
| 07 Jan 2025 | Pengumuman | OraQuick® HIV Self-Test Now Approved for Use in Adolescents |
| 07 Jan 2025 | Pengumuman | OraSure to Present at the J.P Morgan Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |